These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer? Dubois D Curr Opin Pediatr; 2005 Apr; 17(2):227-33. PubMed ID: 15800418 [TBL] [Abstract][Full Text] [Related]
25. The use of atypical antipsychotics in the management of schizophrenia. Campbell M; Young PI; Bateman DN; Smith JM; Thomas SH Br J Clin Pharmacol; 1999 Jan; 47(1):13-22. PubMed ID: 10073734 [TBL] [Abstract][Full Text] [Related]
27. The cost-effectiveness of atypicals in the UK. Heeg B; Buskens E; Botteman M; Caleo S; Ingham M; Damen J; de Charro F; van Hout B Value Health; 2008 Dec; 11(7):1007-21. PubMed ID: 18489517 [TBL] [Abstract][Full Text] [Related]
30. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165 [TBL] [Abstract][Full Text] [Related]
31. Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia. Keck PE; McElroy SL; Strakowski SM; Soutullo CA J Clin Psychiatry; 2000; 61 Suppl 4():33-8. PubMed ID: 10739329 [TBL] [Abstract][Full Text] [Related]
32. Clinical significance of drug binding, protein binding, and binding displacement drug interactions. Jann MW Psychopharmacol Bull; 2002; 36(3):22-41. PubMed ID: 12473962 [TBL] [Abstract][Full Text] [Related]
33. Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia. Ascher-Svanum H; Zhu B; Faries D; Landbloom R; Swartz M; Swanson J BMC Psychiatry; 2006 Feb; 6():8. PubMed ID: 16504026 [TBL] [Abstract][Full Text] [Related]
34. Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents. Toren P; Ratner S; Laor N; Weizman A Drug Saf; 2004; 27(14):1135-56. PubMed ID: 15554747 [TBL] [Abstract][Full Text] [Related]
35. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
36. Treatment of schizoaffective disorder and schizophrenia with mood symptoms. Levinson DF; Umapathy C; Musthaq M Am J Psychiatry; 1999 Aug; 156(8):1138-48. PubMed ID: 10450252 [TBL] [Abstract][Full Text] [Related]
37. [Atypical antipsychotics in the elderly]. van Melick EJ; Tijdschr Gerontol Geriatr; 2004 Dec; 35(6):240-5. PubMed ID: 15704604 [TBL] [Abstract][Full Text] [Related]
38. Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia. Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M J Clin Psychiatry; 2004 Apr; 65(4):551-6. PubMed ID: 15119920 [TBL] [Abstract][Full Text] [Related]
39. [Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study]. Carpiniello B; Mellino G; Pintore S; Puddu L; Pinna F Clin Ter; 2011; 162(4):331-41. PubMed ID: 21912821 [TBL] [Abstract][Full Text] [Related]
40. Antipsychotic prescribing in older people. Neil W; Curran S; Wattis J Age Ageing; 2003 Sep; 32(5):475-83. PubMed ID: 12957993 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]